A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India

IF 6.1 2区 医学 Q1 ONCOLOGY Cancer Pub Date : 2025-01-03 DOI:10.1002/cncr.35702
Divya Khanna MD, Aseem Mishra MCh, Praveen Birur MDS, Tulika Shruti MDS, Keerthi Gurushanth MDS, Nirza Mukhia MDS, Ruchi Pathak DGO, Arjun Gurmeet Singh MDS, Anupama Shetty PhD, Satyajit Pradhan MD, Pankaj Chaturvedi MS
{"title":"A prospective study on diagnostic accuracy of technology-enabled early detection of oral cancer and epidemiology of tobacco and other substances use in rural India","authors":"Divya Khanna MD,&nbsp;Aseem Mishra MCh,&nbsp;Praveen Birur MDS,&nbsp;Tulika Shruti MDS,&nbsp;Keerthi Gurushanth MDS,&nbsp;Nirza Mukhia MDS,&nbsp;Ruchi Pathak DGO,&nbsp;Arjun Gurmeet Singh MDS,&nbsp;Anupama Shetty PhD,&nbsp;Satyajit Pradhan MD,&nbsp;Pankaj Chaturvedi MS","doi":"10.1002/cncr.35702","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Lip and oral cavity cancer is leading cause of cancer mortality among Indian men. This study evaluated diagnostic accuracy of mobile health (mHealth) enabled screening for early detection of oral premalignant lesions or oral cancer (OPML/OC). It also described epidemiology of tobacco and other substance use and associated oral lesions in rural northern India.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A prospective study enrolled 10,101 high-risk individuals from rural settings of Varanasi district, India, between February 2021 and June 2023. Trained field workers captured habits information and oral cavity images and provided screening as suspicious or nonsuspicious on mHealth. Onsite experts and remote specialists provided clinical diagnoses. Diagnostic accuracy of mHealth-enabled screening was evaluated. A subset of 252 participants was followed to assess changes in oral lesions.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Prevalence of substance use was 55.7%, with 21.4% having OPML/OC. Sensitivity of field workers and remote diagnosis for detecting OPML/OC was moderate when compared with onsite expert. Overall, interobserver agreement was substantial. During follow-up, the remote specialists identified 30 new and 13 progressive lesions with a significant decline in the red mean parameter of red, green, and blue colour ratios.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Although mHealth-enabled screening demonstrated lower sensitivity in detecting OPML/OC, their high specificity and expanded access to screening positions mHealth as a valuable tool for improving oral cancer screening coverage in Varanasi. This is particularly crucial given the high burden of oral cancer driven by prevalent smokeless tobacco and areca nut use and the current lack of effective population-based screening programs in this region.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 1","pages":""},"PeriodicalIF":6.1000,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695980/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.35702","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Lip and oral cavity cancer is leading cause of cancer mortality among Indian men. This study evaluated diagnostic accuracy of mobile health (mHealth) enabled screening for early detection of oral premalignant lesions or oral cancer (OPML/OC). It also described epidemiology of tobacco and other substance use and associated oral lesions in rural northern India.

Methods

A prospective study enrolled 10,101 high-risk individuals from rural settings of Varanasi district, India, between February 2021 and June 2023. Trained field workers captured habits information and oral cavity images and provided screening as suspicious or nonsuspicious on mHealth. Onsite experts and remote specialists provided clinical diagnoses. Diagnostic accuracy of mHealth-enabled screening was evaluated. A subset of 252 participants was followed to assess changes in oral lesions.

Results

Prevalence of substance use was 55.7%, with 21.4% having OPML/OC. Sensitivity of field workers and remote diagnosis for detecting OPML/OC was moderate when compared with onsite expert. Overall, interobserver agreement was substantial. During follow-up, the remote specialists identified 30 new and 13 progressive lesions with a significant decline in the red mean parameter of red, green, and blue colour ratios.

Conclusion

Although mHealth-enabled screening demonstrated lower sensitivity in detecting OPML/OC, their high specificity and expanded access to screening positions mHealth as a valuable tool for improving oral cancer screening coverage in Varanasi. This is particularly crucial given the high burden of oral cancer driven by prevalent smokeless tobacco and areca nut use and the current lack of effective population-based screening programs in this region.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一项关于技术支持的口腔癌早期检测诊断准确性和印度农村烟草和其他物质使用流行病学的前瞻性研究。
背景:唇癌和口腔癌是印度男性癌症死亡的主要原因。本研究评估了移动医疗(mHealth)筛查对早期发现口腔恶性病变或口腔癌(OPML/OC)的诊断准确性。研究还描述了印度北部农村地区使用烟草和其他物质以及相关口腔病变的流行病学情况:一项前瞻性研究在 2021 年 2 月至 2023 年 6 月期间从印度瓦拉纳西地区的农村环境中招募了 10101 名高风险人群。训练有素的现场工作人员通过移动医疗采集习惯信息和口腔图像,并提供可疑或非可疑筛查。现场专家和远程专家提供临床诊断。对移动医疗筛查的诊断准确性进行了评估。对 252 名参与者的子集进行了跟踪,以评估口腔病变的变化:结果:使用药物的比例为 55.7%,21.4% 的人患有 OPML/OC。与现场专家相比,现场工作人员和远程诊断检测 OPML/OC 的灵敏度为中等。总体而言,观察者之间的一致性很高。在随访期间,远程专家发现了 30 个新病变和 13 个进展性病变,红、绿、蓝三色比的红色平均参数显著下降:虽然移动医疗筛查在检测 OPML/OC 方面的灵敏度较低,但其特异性高,筛查范围广,因此移动医疗是提高瓦拉纳西口腔癌筛查覆盖率的重要工具。这一点尤为重要,因为无烟烟草和亚麻仁的普遍使用导致口腔癌发病率居高不下,而该地区目前又缺乏有效的人群筛查项目。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
期刊最新文献
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges. Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer. Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI). Utilization and perceptions of chaplaincy among hospitalized adults of Dharmic religions with cancer. Higher rates of long-term complications after prostate cancer treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1